Turn this role into an interview — a resume and cover letter built around what this employer wants.
Scorpion Therapeutics is seeking a Biotransformation Scientist to elucidate enzymatic drug metabolism pathways in preclinical models. This role focuses on identifying key enzymes that metabolize small molecules, peptides, and oligonucleotides, and establishing in vitro-to-in vivo relationships for drug clearance and half-life prediction.
The candidate will design LC-MS/MS and HRMS assays, characterize drug disposition mechanisms, and collaborate with pharmacology and toxicology teams to develop
Role: Biotransformation Scientist focusing on elucidating enzymatic drug metabolism pathways in preclinical models.
Primary objectives include identifying key enzymes involved in metabolizing small molecules, peptides, and oligonucleotides, and establishing in vitro-to-in vivo relationships for drug clearance and half-life prediction.
Responsibilities encompass designing and executing LC-MS/MS and HRMS-based assays, characterizing drug disposition mechanisms, and collaborating with pharmacology and toxicology teams to develop cellular models and platform screening methods.
Requirements: PhD in Chemistry, Biochemistry, or Analytical Chemistry with 2-5 years (postdoctoral) or MSc with 5-7 years biotransformation experience; expertise in contemporary bioanalytical techniques, enzyme kinetics, and mass spectrometry data analysis.
High-value: focus on small molecule, peptide, and oligonucleotide therapeutics, employing in vitro/in vivo ADME studies, with a particular emphasis on drug clearance mechanisms and metabolite structure elucidation.
The role involves laboratory-based research in a regulated environment, potentially exposing individuals to hazardous materials.
The position may be offered at different seniority levels based on experience and education.
Work setup: typical laboratory environment, with safety precautions due to chemical and biological hazards.